Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Julie K Rajaratnam"'
Autor:
Haribondhu Sarma, Ashwin Budden, Sharmin Khan Luies, Stephen S. Lim, Md. Shamsuzzaman, Tahmina Sultana, Julie K. Rajaratnam, Laura Craw, Cathy Banwell, Md. Wazed Ali, Md. Jasim Uddin
Publikováno v:
BMC Public Health, Vol 19, Iss 1, Pp 1-10 (2019)
Abstract Background Gavi, the Vaccine Alliance, supported a mass vaccination Measles-Rubella Campaign (MRC) in Bangladesh during January–February 2014. Methods We conducted a mixed-method process evaluation to understand the successes and challenge
Externí odkaz:
https://doaj.org/article/652fee0a2ce146d2ab48252909683604
Autor:
Nicole Salisbury, Moses Simuyemba, Gilbert Asiimwe, Jessica Shearer, Emily Carnahan, Dai Hozumi, Julie K Rajaratnam, Felix Masiye, Jasim Uddin, Caroline Soi, Baltazar Chilundo, Haribondhu Sarma, Moses Kamya, Sarah Gimbel, Ashwin Budden, Stephen S Lim
Publikováno v:
Health Policy and Planning
Vaccination, like most other public health services, relies on a complex package of intervention components, functioning systems and committed actors to achieve universal coverage. Despite significant investment in immunization programmes, national c
Autor:
Cathy Banwell, Md. Jasim Uddin, Sharmin Khan Luies, Laura Craw, Mohammad Wazed Ali, Haribondhu Sarma, Ashwin Budden, Stephen S Lim, Julie K Rajaratnam, Tahmina Sultana, Mohammad Shamsuzzaman
Publikováno v:
BMC Public Health, Vol 19, Iss 1, Pp 1-10 (2019)
BMC Public Health
BMC Public Health
Background Gavi, the Vaccine Alliance, supported a mass vaccination Measles-Rubella Campaign (MRC) in Bangladesh during January–February 2014. Methods We conducted a mixed-method process evaluation to understand the successes and challenges in impl
Autor:
Kelly S. Willis, Marcia R. Weaver, Mary Lou Thompson, Jolene Wun, Martin Mbonye, Julie K Rajaratnam
Publikováno v:
The Lancet. 381:S146
Background Due to shortage of health personnel in sub-Saharan Africa, WHO advocates shifting some tasks traditionally performed by doctors to mid-level practitioners (MLPs). The effect on under-5 (U5) mortality of an on-site support (OSS) interventio